Clinical Trial

Observational Study on the Variation of Ascorbic Acid in Patients Undergoing Solid Organ Transplantation

Study acronym: REDOX-TX
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this observational clinical study is to evaluate the variations in ascorbic acid during the transplantation phases and how these variations influence the oxidative status and patient outcome. The main questions it aims to answer are: * how many patients arrive at the transplant in a state of hypovitaminosis C? * how does hypovitaminosis C affect the patient's oxidative status? * how does hypovitaminosis C affect the length of stay in intensive care and post-transplant complications?
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-29.
Status change: Recruiting → Active, Not Recruiting 2024-09-01
Trial Details
NCT Number NCT06395259
Lead Sponsor Policlinico Hospital
Conditions Transplantation, Ascorbic Acid Deficiency
Enrollment 40 participants
Start Date 2023-02-01
Primary Completion 2024-08-31 (estimated)
Study Completion 2024-08-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-04